The Cost-Effectiveness of Early High-Acuity Postoperative Care for Medium-Risk Surgical Patients

被引:4
作者
Leaman, Esrom E. [1 ,2 ]
Ludbrook, Guy L. [1 ,2 ]
机构
[1] Royal Adelaide Hosp, Dept Anaesthesia, 3G 395,1 N Terr, Adelaide 5000, Australia
[2] Univ Adelaide, Discipline Acute Care Med, Adelaide, Australia
关键词
SURGERY; MORTALITY; LENGTH; STAY;
D O I
10.1213/ANE.0000000000006743
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND:Initiatives in perioperative care warrant robust cost-effectiveness analysis in a cost-constrained era when high-value care is a priority. A model of anesthesia-led early high-acuity postoperative care, advanced recovery room care (ARRC), has shown benefit in terms of hospital and patient outcomes, but its cost-effectiveness has not yet been formally determined.METHODS:Data from a previously published single-center prospective cohort study of ARRC in medium-risk patients were used to generate a Markov model, which described patient transition between care locations, each with different characteristics and costs. The incremental cost-effectiveness ratio (ICER), using days at home (DAH) and hospital costs, was calculated for ARRC compared to usual ward care using deterministic and probabilistic sensitivity analysis.RESULTS:The Markov model accurately described patient disposition after surgery. For each patient, ARRC provided 4.3 more DAH within the first 90 days after surgery and decreased overall hospital costs by $1081 per patient. Probabilistic sensitivity analysis revealed that ARRC had a 99.3% probability of increased DAH and a 77.4% probability that ARRC was dominant from the perspective of the hospital, with improved outcomes and decreased costs.CONCLUSIONS:Early high-acuity care for approximately 24 hours after surgery in medium-risk patients provides highly cost-effective improvements in outcomes when compared to usual ward care.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 25 条
  • [1] Why Cost-Effectiveness?
    Bartha, Erzsebet
    [J]. ANESTHESIA AND ANALGESIA, 2018, 127 (05) : 1107 - 1108
  • [2] Days at Home after Surgery: An Integrated and Efficient Outcome Measure for Clinical Trials and Quality Assurance
    Bell, Max
    Eriksson, Lars, I
    Svensson, Tobias
    Hallqvist, Linn
    Granath, Fredrik
    Reilly, Jennifer
    Myles, Paul S.
    [J]. ECLINICALMEDICINE, 2019, 11 : 18 - 26
  • [3] Briggs A., 2006, DECISION MODELLING H
  • [4] Assessment of Potentially Preventable Hospital Readmissions After Major Surgery and Association With Public vs Private Health Insurance and Comorbidities
    Brown, Craig S.
    Montgomery, John R.
    Neiman, Pooja U.
    Wakam, Glenn K.
    Tsai, Thomas C.
    Dimick, Justin B.
    Scott, John W.
    [J]. JAMA NETWORK OPEN, 2021, 4 (04) : E215503
  • [5] A clinical pathway in a post-anaesthesia care unit to reduce length of stay, mortality and unplanned intensive care unit admission
    Eichenberger, Alain-S
    Haller, Guy
    Cheseaux, Nicole
    Lechappe, Vincent
    Garnerin, Philippe
    Walder, Bernhard
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2011, 28 (12) : 859 - 866
  • [6] Minimal clinically important difference in days at home up to 30 days after surgery
    Ferguson, M. T.
    Kusre, S.
    Myles, P. S.
    [J]. ANAESTHESIA, 2022, 77 (02) : 196 - 200
  • [7] Filipovic-Pierucci A., arXiv
  • [8] Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia
    Fine, MJ
    Pratt, HM
    Obrosky, DS
    Lave, JR
    McIntosh, LJ
    Singer, DE
    Coley, CM
    Kapoor, WN
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 109 (05) : 378 - 385
  • [9] Gabadinho A, 2011, J STAT SOFTW, V40, P1
  • [10] Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
    Garrison, Louis R., Jr.
    Lubeck, Deborah
    Lalla, Deepa
    Paton, Virginia
    Dueck, Amylou
    Perez, Edith A.
    [J]. CANCER, 2007, 110 (03) : 489 - 498